Management of primary central nervous system lymphoma for the patient with acquired immunodeficiency syndrome. Confronting a clinical catch-22

Systemic chemotherapy alone for patients

Systemic chemotherapy alone for patients with non-acquired immunodeficiency syndrome-related central nervous system lymphoma : A pilot study of the BOMES protocol

✍ Ann-Lii Cheng; Kun-Huei Yeh; Wu-Ching Uen; Ruey-Long Hung; Mei-Ying Liu; Chiu-Hw 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB 👁 2 views

## BACKGROUND. Anecdotal reports have suggested that systemic chemotherapy with agents that better cross the blood-brain barrier may result in long term disease Kun-Huei Yeh, M.D. 2, remission in some patients with central nervous system (CNS) lymphoma. This Wu-Ching Uen, M.D. 2 treatment strategy